A single nucleotide polymorphism associated with isolated cleft lip and palate, thyroid cancer and hypothyroidism alters the activity of an oral epithelium and thyroid enhancer near FOXE1

Human Molecular Genetics

Volumn 24, Issue 14, 2015, Pages 3895-3907

  Lidral, Andrew C ^a   Liu, Huan ^b,c   Bullard, Steven A ^a   Bonde, Greg ^a   Machida, Junichiro ^d   Visel, Axel ^e,f   Uribe, Lina M Moreno ^a   Li, Xiao ^a   Amendt, Brad ^a   Cornell, Robert A ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c WUHAN UNIVERSITY   (China)

^d TOYOTA MEMORIAL HOSPITAL   (Japan)

^e LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^f DOE JOINT GENOME INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOXE1 PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ENHANCED GREEN FLUORESCENT PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; FOXE1 PROTEIN, HUMAN; FOXE1 PROTEIN, MOUSE; GREEN FLUORESCENT PROTEIN;

ALLELE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRANCHIAL ARCH; CLEFT LIP PALATE; CONTROLLED STUDY; DNA SCREENING; EMBRYO; ENHANCER REGION; FISH MODEL; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC RISK; HEART; HUMAN; HUMAN CELL; HYPOTHYROIDISM; MOUSE; MOUTH MUCOSA; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; START CODON; THYROID CANCER; THYROID CELL; TRANSGENICS; ZEBRA FISH; ANIMAL; CELL LINE; CLEFT LIP; CLEFT PALATE; CYTOLOGY; EMBRYOLOGY; EPITHELIUM; EPITHELIUM CELL; GENE LOCUS; GENETICS; METABOLISM; MOLECULAR CLONING; PALATE; PROMOTER REGION; THYROID GLAND; THYROID TUMOR; TRANSGENIC MOUSE;

DANIO RERIO;

ALLELES; ANIMALS; CELL LINE; CLEFT LIP; CLEFT PALATE; CLONING, MOLECULAR; EPITHELIAL CELLS; EPITHELIUM; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC LOCI; GREEN FLUORESCENT PROTEINS; HUMANS; HYPOTHYROIDISM; MICE; MICE, TRANSGENIC; PALATE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; THYROID GLAND; THYROID NEOPLASMS; ZEBRAFISH;

EID: 84936804773     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv047     Document Type: Article

References (87)

1. Mitchell, L.E., Christensen, K. et al. (1997) Evaluation of family history data for Danish twins with nonsyndromic cleft lip with or without cleft palate. Am. J. Med. Genet., 72, 120-121.
2. Grant, S.F., Wang, K., Zhang, H., Glaberson, W., Annaiah, K., Kim, C.E., Bradfield, J.P., Glessner, J.T., Thomas, K.A., Garris, M. et al. (2009) A genome-wide association study identifies a locus for nonsyndromic cleft lip with or without cleft palate on 8q24. J. Pediatr., 155, 909-913.
3. Mangold, E., Ludwig, K.U., Birnbaum, S., Baluardo, C., Ferrian, M., Herms, S., Reutter, H., de Assis, N.A., Chawa, T.A., Mattheisen, M. et al. (2010) Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate. Nat. Genet., 42, 24-26.
4. Beaty, T.H., Murray, J.C., Marazita, M.L., Munger, R.G., Ruczinski, I., Hetmanski, J.B., Liang, K.Y., Wu, T., Murray, T., Fallin, M.D. et al. (2010) A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4. Nat. Genet., 42, 525-531.
5. Ludwig, K.U., Mangold, E., Herms, S., Nowak, S., Reutter, H., Paul, A., Becker, J., Herberz, R., AlChawa, T., Nasser, E. et al. (2012) Genome-wide meta-analyses of nonsyndromic cleft lip with or without cleft palate identify six new risk loci. Nat. Genet., 44, 968-971.
6. Manolio, T.A. (2010) Genomewide association studies and assessment of the risk of disease. N. Engl. J. Med., 363, 166-176.
7. Dixon, M.J., Marazita, M.L., Beaty, T.H. and Murray, J.C. (2011) Cleft lip and palate: understanding genetic and environmental influences. Nat. Rev. Genet., 12, 167-178.
8. Leslie, E.J. and Marazita, M.L. (2013) Genetics of cleft lip and cleft palate. Am. J. Med. Genet. C Semin. Med. Genet., 163, 246-258.
9. Moreno, L.M., Mansilla, M.A., Bullard, S.A., Cooper, M.E., Busch, T.D., Machida, J., Johnson, M.K., Brauer, D., Krahn, K., Daack-Hirsch, S. et al. (2009) FOXE1 association with both isolated cleft lip with or without cleft palate, and isolated cleft palate. Hum. Mol. Genet., 18, 4879-4896.
10. Nikopensius, T., Kempa, I., Ambrozaityte˙, L., Jagomägi, T., Saag, M., Matulevičiene˙, A., Utkus, A., Krjutškov, K., Tammekivi, V., Piekuse, L. et al. (2011) Variation in FGF1, FOXE1, and TIMP2genes is associated with nonsyndromic cleft lip with or without cleft palate. Birth Defects Res. A Clin. Mol. Teratol., 91, 218-225.
11. Ludwig, K.U., Böhmer, A.C., Rubini, M., Mossey, P.A., Herms, S., Nowak, S., Reutter, H., Alblas, M.A., Lippke, B., Barth, S. et al. (2014) Strong association of variants around FOXE1 and orofacial clefting. J. Dent. Res., 93, 376-381.
12. Lennon, C.J., Birkeland, A.C., Nuñez, J.A.P., Su, G.H., Lanzano, P., Guzman, E., Celis, K., Eisig, S.B., Hoffman, D., Rendon, M.T. G. et al. (2012) Association of candidate genes with nonsyndromic clefts in Honduran and Colombian populations. Laryngoscope, 122, 2082-2087.
13. Castanet, M., Park, S.-M., Smith, A., Bost, M., Leger, J., Lyonnet, S., Pelet, A., Czernichow, P., Chatterjee, K. and Polak, M. (2002) A novel loss-of-function mutation in TTF-2 is associated with congenital hypothyroidism, thyroid agenesis and cleft palate. Hum. Mol. Genet., 11, 2051-2059.
14. Clifton-Bligh, R.J., Wentworth, J.M., Heinz, P., Crisp, M.S., John, R., Lazarus, J.H., Ludgate, M. and Chatterjee, V.K. (1998) Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nat. Genet., 19, 399-401.
15. Baris, I., Arisoy, A.E., Smith, A., Agostini, M., Mitchell, C.S., Park, S.M., Halefoglu, A.M., Zengin, E., Chatterjee, V.K. and Battaloglu, E. (2006) A novel missense mutation in human TTF-2 (FKHL15) gene associated with congenital hypothyroidism but not athyreosis. J. Clin. Endocrinol. Metab., 91, 4183-4187.
16. De Felice, M., Ovitt, C., Biffali, E., Rodriguez-Mallon, A., Arra, C., Anastassiadis, K., Macchia, P.E., Mattei, M.G., Mariano, A., Scholer, H. et al. (1998) A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat. Genet., 19, 395-398.
17. Hishinuma, A., Ohyama, Y., Kuribayashi, T., Nagakubo, N., Namatame, T., Shibayama, K., Arisaka, O., Matsuura, N. and Ieiri, T. (2001) Polymorphism of the polyalanine tract of thyroid transcription factor-2 gene in patients with thyroid dysgenesis. Eur. J. Endocrinol., 145, 385-389.
18. Carré, A., Castanet, M., Sura-Trueba, S., Szinnai, G., Vliet, G., Trochet, D., Amiel, J., Léger, J., Czernichow, P., Scotet, V. et al. (2007) Polymorphic length of FOXE1 alanine stretch: evidence for genetic susceptibility to thyroid dysgenesis. Hum. Genet., 122, 467-476.
19. Szczepanek, E., Ruchala, M., Szaflarski, W., Budny, B., Kilinska, L., Jaroniec, M., Niedziela, M., Zabel, M. and Sowinski, J. (2011) FOXE1 polyalanine tract length polymorphism in patients with thyroid hemiagenesis and subjects with normal thyroid. Horm. Res. Paediatr., 75, 329-334.
20. Eriksson, N., Tung, J.Y., Kiefer, A.K., Hinds, D.A., Francke, U., Mountain, J.L. and Do, C.B. (2012) Novel associations for hypothyroidism include known autoimmune risk loci. PLoS One, 7, e34442.
21. Denny, J.C., Crawford, D.C., Ritchie, M.D., Bielinski, S.J., Basford, M.A., Bradford, Y., Chai, H.S., Bastarache, L., Zuvich, R., Peissig, P. et al. (2011) Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome-and phenome-wide studies. Am. J. Hum. Genet., 89, 529-542.
22. Tomaz, R.A., Sousa, I., Silva, J.G., Santos, C., Teixeira, M.R., Leite, V. and Cavaco, B.M. (2012) FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility. Clin. Endocrinol. (Oxf)., 77, 926-933.
23. Bonora, E., Rizzato, C., Diquigiovanni, C., Oudot-Mellakh, T., Campa, D., Vargiolu, M., Guedj, M., McKay, J.D., Romeo, G., Canzian, F. et al. (2014) The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma. Int. J. Cancer, 134, 2098-2107.
24. Bullock, M., Duncan, E.L., O'Neill, C., Tacon, L., Sywak, M., Sidhu, S., Delbridge, L., Learoyd, D., Robinson, B.G., Ludgate, M. et al. (2012) Association of FOXE1 polyalanine repeat region with papillary thyroid cancer. J. Clin. Endocrinol. Metab., 97, E1814-E1819.
25. Matsuse, M., Takahashi, M., Mitsutake, N., Nishihara, E., Hirokawa, M., Kawaguchi, T., Rogounovitch, T., Saenko, V., Bychkov, A., Suzuki, K. et al. (2011) The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population. J. Med. Genet., 48, 645-648.
26. Landa, I., Ruiz-Llorente, S., Montero-Conde, C., Inglada-Pérez, L., Schiavi, F., Leskelä, S., Pita, G., Milne, R., Maravall, J., Ramos, I. et al. (2009) The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS Genet., 5, e1000637.
27. Zhan, M., Chen, G., Pan, C.-M., Gu, Z.-H., Zhao, S.-X., Liu, W., Wang, H.-N., Ye, X.-P., Xie, H.-J., Yu, S.-S. et al. (2014) Genomewide association study identifies a novel susceptibility gene for serum TSH levels in Chinese populations. Hum. Mol. Genet., 23, 5505-5517.
28. Damiola, F., Byrnes, G., Moissonnier, M., Pertesi, M., Deltour, I., Fillon, A., Le Calvez-Kelm, F., Tenet, V., McKay-Chopin, S., McKay, J.D. et al. (2014) Contribution of ATM and FOXE1 (TTF2) to risk of papillary thyroid carcinoma in Belarusian children exposed to radiation. Int. J. Cancer, 134, 1659-1668.
29. Takahashi, M., Saenko, V.A., Rogounovitch, T.I., Kawaguchi, T., Drozd, V.M., Takigawa-Imamura, H., Akulevich, N.M., Ratanajaraya, C., Mitsutake, N., Takamura, N. et al. (2010) The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum. Mol. Genet., 19, 2516-2523.
30. Gudmundsson, J., Sulem, P., Gudbjartsson, D.F., Jonasson, J. G., Sigurdsson, A., Bergthorsson, J.T., He, H., Blondal, T., Geller, F., Jakobsdottir, M. et al. (2009) Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat. Genet., 41, 460-464.
31. Kallel, R., Belguith-Maalej, S., Akdi, A., Mnif, M., Charfeddine, I., Galofré, P., Ghorbel, A., Abid, M., Marcos, R., Ayadi, H. et al. (2010) Genetic investigation of FOXE1 polyalanine tract in thyroid diseases: new insight on the role of FOXE1 in thyroid carcinoma. Cancer Biomark., 8, 43-51.
32. Kohler, A., Chen, B., Gemignani, F., Elisei, R., Romei, C., Figlioli, G., Cipollini, M., Cristaudo, A., Bambi, F., Hoffmann, P. et al. (2013) Genome-wide association study on differentiated thyroid cancer. J. Clin. Endocrinol. Metab., 98, E1674-E1681.
33. Medici, M., van der Deure, W.M., Verbiest, M., Vermeulen, S. H., Hansen, P.S., Kiemeney, L.A., Hermus, A.R.M.M., Breteler, M.M., Hofman, A., Hegedüs, L. et al. (2011) A largescale association analysis of 68 thyroid hormone pathway genes with serum TSH and FT4 levels. Eur. J. Endocrinol., 164, 781-788.
34. Lowe, J.K., Maller, J.B., Pe'er, I., Neale, B.M., Salit, J., Kenny, E.E., Shea, J.L., Burkhardt, R., Smith, J.G., Ji, W. et al. (2009) Genomewide association studies in an isolated founder population from the Pacific Island of Kosrae. PLoS Genet, 5, e1000365.
35. Comuzzie, A.G., Cole, S.A., Laston, S.L., Voruganti, V.S., Haack, K., Gibbs, R.A. and Butte, N.F. (2012) Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population. PLoS One, 7, e51954.
36. Alul, F.Y., Shchelochkov, O.A., Berberich, S.L., Murray, J.C. and Ryckman, K.K. (2013) Genetic associations with neonatal thyroid-stimulating hormone levels. Pediatr. Res., 73, 484-491.
37. Porcu, E., Medici, M., Pistis, G., Volpato, C.B., Wilson, S.G., Cappola, A.R., Bos, S.D., Deelen, J., den Heijer, M., Freathy, R.M. et al. (2013) A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genet, 9, e1003266.
38. Santisteban, P., Acebrón, A., Polycarpou-Schwarz, M. and Di Lauro, R. (1992) Insulin and insulin-like growth factor I regulate a thyroid-specific nuclear protein that binds to the thyroglobulin promoter. Mol. Endocrinol., 6, 1310-1317.
39. Fisher, S., Grice, E.A., Vinton, R.M., Bessling, S.L., Urasaki, A., Kawakami, K. and McCallion, A.S. (2006) Evaluating the biological relevance of putative enhancers using Tol2 transposon-mediated transgenesis in zebrafish. Nat. Protoc., 1, 1297-1305.
40. Attanasio, C., Nord, A.S., Zhu, Y., Blow, M.J., Li, Z., Liberton, D. K., Morrison, H., Plajzer-Frick, I., Holt, A., Hosseini, R. et al. (2013) Fine tuning of craniofacial morphology by distant-acting enhancers. Science, 342.
41. Nakada, C., Iida, A., Tabata, Y. and Watanabe, S. (2009) Forkhead transcription factor foxe1 regulates chondrogenesis in zebrafish. J. Exp. Zool. B Mol. Dev. Evol., 312B, 827-840.
42. Ambesi-Impiombato, F.S., Parks, L.A. and Coon, H.G. (1980) Culture of hormone-dependent functional epithelial cells from rat thyroids. Proc. Natl Acad. Sci. USA, 77, 3455-3459.
43. Mathelier, A., Zhao, X., Zhang, A.W., Parcy, F., Worsley-Hunt, R., Arenillas, D.J., Buchman, S., Chen, C.-Y., Chou, A., Ienasescu, H. et al. (2014) JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles. Nucleic Acids Res., 42, D142-D147.
44. Zannini, M., Avantaggiato, V., Biffali, E., Arnone, M.I., Sato, K., Pischetola, M., Taylor, B.A., Phillips, S.J., Simeone, A. and Di Lauro, R. (1997) TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation. EMBO J., 16, 3185-3197.
45. Diez-Roux, G., Banfi, S., Sultan, M., Geffers, L., Anand, S., Rozado, D., Magen, A., Canidio, E., Pagani, M., Peluso, I. et al. (2011) A high-resolution anatomical atlas of the transcriptome in the mouse embryo. PLoS Biol., 9, e1000582.
46. Fisher, S., Grice, E.A., Vinton, R.M., Bessling, S.L. and McCallion, A.S. (2006) Conservation of RET regulatory function from human to zebrafish without sequence similarity. Science, 312, 276-279.
47. McGaughey, D., Stine, Z., Huynh, J., Vinton, R. andMcCallion, A. (2009) Asymmetrical distribution of non-conserved regulatory sequences at PHOX2B is reflected at the ENCODE loci and illuminates a possible genome-wide trend. BMC Genomics, 10, 8.
48. Rioux, J.D., Xavier, R.J., Taylor, K.D., Silverberg, M.S., Goyette, P., Huett, A., Green, T., Kuballa, P., Barmada, M.M., Datta, L.W. et al. (2007) Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet., 39, 596-604.
49. Trochet, D., Bourdeaut, F., Janoueix-Lerosey, I., Deville, A., de Pontual, L., Schleiermacher, G., Coze, C., Philip, N., Frébourg, T., Munnich, A. et al. (2004) Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. Am. J. Hum. Genet., 74, 761-764.
50. Kapoor, A., Sekar, R.B., Hansen, N.F., Fox-Talbot, K., Morley, M., Pihur, V., Chatterjee, S., Brandimarto, J., Moravec, C.S., Pulit, S.L. et al. (2014) An enhancer polymorphism at the cardiomyocyte intercalated disc protein NOS1AP locus is a major regulator of the QT interval. Am. J. Hum. Genet., 94, 854-869.
51. Hadzhiev, Y., Lele, Z., Schindler, S., Wilson, S., Ahlberg, P., Strahle, U. and Muller, F. (2007) Hedgehog signaling patterns the outgrowth of unpaired skeletal appendages in zebrafish. BMC Dev. Biol., 7, 75.
52. Royo, J.L., Hidalgo, C., Roncero, Y., Seda, M.A., Akalin, A., Lenhard, B., Casares, F. and Gómez-Skarmeta, J.L. (2011) Dissecting the transcriptional regulatory properties of human chromosome 16 highly conserved non-coding regions. PLoS One, 6, e24824.
53. Olivieri, A., Stazi, M.A., Mastroiacovo, P., Fazzini, C., Medda, E., Spagnolo, A., De Angelis, S., Grandolfo, M.E., Taruscio, D., Cordeddu, V. et al. (2002) A population-based study on the frequency of additional congenital malformations in infants with congenital hypothyroidism: data from the Italian Registry for Congenital Hypothyroidism (1991-1998). J. Clin. Endocrinol. Metab., 87, 557-562.
54. Devos, H., Rodd, C., Gagné, N., Laframboise, R. and Van Vliet, G. (1999) A search for the possible molecular mechanisms of thyroid dysgenesis: sex ratios and associated malformations. J. Clin. Endocrinol. Metab., 84, 2502-2506.
55. Carre, A., Hamza, R.T., Kariyawasam, D., Guillot, L., Teissier, R., Tron, E., Castanet, M., Dupuy, C., El Kholy, M. and Polak, M. (2014)Anovel FOXE1 mutation (R73S) in Bamforth-Lazarus syndrome causing increased thyroidal gene expression. Thyroid, 24, 649-654.
56. Meng, T., Shi, J.-Y., Wu, M., Wang, Y., Li, L., Liu, Y., Zheng, Q., Huang, L. and Shi, B. (2012) Overexpression of mouse TTF-2 gene causes cleft palate. J. Cell. Mol. Med., 16, 2362-2368.
57. Puxeddu, E., Knauf, J.A., Sartor, M.A., Mitsutake, N., Smith, E.P., Medvedovic, M., Tomlinson, C.R., Moretti, S. and Fagin, J.A. (2005) RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response. Endocr. Relat. Cancer, 12, 319-334.
58. Holmberg, E., Rozell, B.L. and Toftgard, R. (1996) Differential allele loss on chromosome 9q22.3 in human non-melanoma skin cancer. Br. J. Cancer, 74, 246-250.
59. Venza, I., Visalli, M., Tripodo, B., De Grazia, G., Loddo, S., Teti, D. and Venza, M. (2010) FOXE1 is a target for aberrant methylation in cutaneous squamous cell carcinoma. Br. J. Dermatol., 162, 1093-1097.
60. Sato, N., Fukushima, N., Maitra, A., Matsubayashi, H., Yeo, C. J., Cameron, J.L., Hruban, R.H. and Goggins, M. (2003) Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res., 63, 3735-3742.
61. Bell, A., Bell, D., Weber, R.S. and El-Naggar, A.K. (2011) CpG island methylation profiling in human salivary gland adenoid cystic carcinoma. Cancer, 117, 2898-2909.
62. Weisenberger, D.J., Trinh, B.N., Campan, M., Sharma, S., Long, T.I., Ananthnarayan, S., Liang, G., Esteva, F.J., Hortobagyi, G. N., McCormick, F. et al. (2008) DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight. Nucleic Acids Res., 36, 4689-4698.
63. Papadia, C., Louwagie, J., Del Rio, P., Grooteclaes, M., Coruzzi, A., Montana, C., Novelli, M., Bordi, C., de' Angelis, G.L., Bassett, P. et al. (2014) FOXE1 and SYNE1 genes hypermethylation panel as promising biomarker in colitis-associated colorectal neoplasia. Inflamm. Bowel Dis., 20, 271-277.
64. Nonaka, D., Tang, Y., Chiriboga, L., Rivera, M. and Ghossein, R. (2007) Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms. Mod. Pathol., 21, 192-200.
65. He, H., Li, W., Liyanarachchi, S., Jendrzejewski, J., Srinivas, M., Davuluri, R.V., Nagy, R. and de la Chapelle, A. (2015) Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2. J. Clin. Endocrinol. Metab., 100, E164-E172.
66. Aitola, M.H. and Pelto-Huikko, M.T. (2003) Expression of Arnt and Arnt2 mRNA in developing murine tissues. J. Histochem. Cytochem., 51, 41-54.
67. Abbott, B.D. and Probst, M.R. (1995) Developmental expression of two members of a new class of transcription factors: II. Expression of Aryl Hydrocarbon Receptor Nuclear Translocator in the C57BL/6N Mouse Embryo. Dev. Dyn., 204, 144-155.
68. Jain, S., Maltepe, E., Lu, M.M., Simon, C. and Bradfield, C.A. (1998) Expression of ARNT, ARNT2, HIF1a, HIF2a and Ah receptor mRNAs in the developing mouse. Mech. Dev., 73, 117-123.
69. Pratt, R.M., Dencker, L. and Diewert, V.M. (1984) 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin-induced cleft palate in the mouse: evidence for alterations in palatal shelf fusion. Teratog. Carcinog. Mutagen., 4, 427-436.
70. García, A.M., Fletcher, T., Benavides, F.G. and Orts, E. (1999) Parental agricultural work and selected congenital malformations. Am. J. Epidemiol., 149, 64-74.
71. Wyszynski, D.F., Duffy, D.L. and Beaty, T.H. (1997) Maternal cigarette smoking and oral clefts: a meta-analysis. Cleft Palate. Craniofac. J., 34, 206-210.
72. Kayano, S., Suzuki, Y., Kanno, K., Aoki, Y., Kure, S., Yamada, A. and Matsubara, Y. (2004) Significant association between nonsyndromic oral clefts and arylhydrocarbon receptor nuclear translocator (ARNT). Am. J. Med. Genet., 130A, 40-44.
73. Giacomini, S., Hou, L., Bertazzi, P. and Baccarelli, A. (2006) Dioxin effects on neonatal and infant thyroid function: routes of perinatal exposure, mechanisms of action and evidence from epidemiology studies. Int. Arch. Occup. Environ. Health, 79, 396-404.
74. Yokoyama, S., Ito, Y., Ueno-Kudoh, H., Shimizu, H., Uchibe, K., Albini, S., Mitsuoka, K., Miyaki, S., Kiso, M., Nagai, A. et al. (2009) A systems approach reveals that the myogenesis genome network is regulated by the transcriptional repressor RP58. Dev. Cell, 17, 836-848.
75. Kitase, Y. and Shuler, C.F. (2013) Microtubule disassembly prevents palatal fusion and alters regulation of the E-cadherin/catenin complex. Int. J. Dev. Biol., 57, 55-60.
76. Wei, K., Chen, J., Akrami, K., Galbraith, G.C., Lopez, I.A. and Chen, F. (2007) Neural crest cell deficiency of c-myc causes skull and hearing defects. Genesis, 45, 382-390.
77. Zhu, X., Zhao, L., Park, J.W., Willingham, M.C. and Cheng, S.-Y. (2014) Synergistic signaling of KRAS and thyroid hormone receptor ß mutants promotes undifferentiated thyroid cancer through MYC up-regulation. Neoplasia, 16, 757-769.
78. Van Otterloo, E., Li, W., Garnett, A., Cattell, M., Medeiros, D.M. and Cornell, R.A. (2012) Novel Tfap2-mediated control of soxE expression facilitated the evolutionary emergence of the neural crest. Development, 139, 720-730.
79. Siepel, A., Bejerano, G., Pedersen, J.S., Hinrichs, A.S., Hou, M., Rosenbloom, K., Clawson, H., Spieth, J., Hillier, L.W., Richards, S. et al. (2005) Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res., 15, 1034-1050.
80. Eichberger, T., Regl, G., Ikram, M.S., Neill, G.W., Philpott, M.P., Aberger, F. and Frischauf, A.-M. (2004) FOXE1, a new transcriptional target of GLI2 is expressed in human epidermis and basal cell carcinoma. J. Invest. Dermatol., 122, 1180-1187.
81. Kent, W.J. (2002) BLAT-the BLAST-like alignment tool. Genome Res., 12, 656-664.
82. Suster, M., Kikuta, H., Urasaki, A., Asakawa, K. and Kawakami, K. (2009) Transgenesis in zebrafish with the Tol2 transposon system. In Cartwright, E.J. (ed.), Transgenesis Techniques. Humana Press, New York, NY, Vol. 561, pp. 41-63.
83. McGaughey, D.M., Vinton, R.M., Huynh, J., Al-Saif, A., Beer, M. A. and McCallion, A.S. (2008) Metrics of sequence constraint overlook regulatory sequences in an exhaustive analysis at phox2b. Genome Res., 18, 252-260.
84. Pennacchio, L.A., Ahituv, N., Moses, A.M., Prabhakar, S., Nobrega, M.A., Shoukry, M., Minovitsky, S., Dubchak, I., Holt, A., Lewis, K.D. et al. (2006) In vivo enhanceranalysis ofhumanconserved non-coding sequences. Nature, 444, 499-502.
85. Heckman, K.L. and Pease, L.R. (2007) Gene splicing and mutagenesis by PCR-driven overlap extension. Nat. Protoc., 2, 924-932.
86. Hemann, M.T., Bric, A., Teruya-Feldstein, J., Herbst, A., Nilsson, J.A., Cordon-Cardo, C., Cleveland, J.L., Tansey, W.P. and Lowe, S.W. (2005) Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature, 436, 807-811.
87. Gilchrist, E.P., Moyer, M.P., Shillitoe, E.J., Clare, N. and Murrah, V.A. (2000) Establishment of a human polyclonal oral epithelial cell line. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 90, 340-347.